 |
|
|
| |
Novel and Potent HBV Capsid Modulator Reduces HBeAg and cccDNA
in Core-site Directed T109I Mutant in HepNTCP Cells
|
| |
| |
Dr Schinazi présents the structure which apparently is not generally done.br clear="all" />
Reported by Jules Levn
EASL 2018 april 11-15 Paris Francebr clear="all" />
Leda Bassit1, Bryan Cox1, Suzane K Ono2, Kiran Verma1, Jack Yoon1,
Franck Amblard1, and Raymond F Schinazi1*
1Center for AIDS Research, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA. 2Department of Gastroenterology, University of São Paulo School of Medicine, Sao Paulo, Brazil.
|
| |
|
|
|
|
|
